MedTrace Logo

Cognition in Allogeneic Stem Cell Transplanted Patients and Sports

NCT02533947 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2019-04-30

No results posted yet for this study

Summary

Studies suggest that patients with hematological malignancies undergoing allogeneic hematopoietic stem cell transplantation (HSCT) are at risk for cognitive decline and long-term cognitive dysfunction. To address this issue, a randomized controlled intervention trial on the effect of physical exercise on cognition is conducted. In addition, the impact on psychological and physical health outcomes is evaluated. Results may benefit patients who suffer from disease- or treatment-associated cognitive change.

Conditions

  • Allogeneic Stem Cell Transplantation
  • Exercise Intervention

Interventions

BEHAVIORAL

Exercise

The intervention consists of an individually tailored supervised exercise program with aerobic, strength and coordinative components.

BEHAVIORAL

Control

A waitlist control group will get the intervention after 7 month of treatment as usual.

Sponsors & Collaborators

  • Deutsche José Carreras Leukämie-Stiftung (DJCLS)

    collaborator UNKNOWN

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • Karl-Heinz Schulz, Prof.Dr.Dr. · Universitätsklinikum Hamburg-Eppendorf

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2019-05-31
Completion
2019-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02533947 on ClinicalTrials.gov